Mind Medicine Inc (NASDAQ: MNMD) is -6.47% lower on its value in year-to-date trading and has touched a low of $3.49 and a high of $12.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MNMD stock was last observed hovering at around $6.76 in the last trading session, with the day’s loss setting it -0.25%.
Currently trading at $6.51, the stock is -8.37% and -11.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing -3.70% at the moment leaves the stock -13.05% off its SMA200. MNMD registered 69.09% gain for a year compared to 6-month loss of -22.41%. The firm has a 50-day simple moving average (SMA 50) of $7.3546 and a 200-day simple moving average (SMA200) of $7.502525.
The stock witnessed a -9.08% gain in the last 1 month and extending the period to 3 months gives it a 10.06%, and is -7.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.83% over the week and 9.18% over the month.
Mind Medicine Inc (MNMD) has around 57 employees, a market worth around $477.39M and $0.00M in sales. Distance from 52-week low is 86.53% and -46.73% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.14%).
The EPS is expected to grow by 40.57% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
213.0 institutions hold shares in Mind Medicine Inc (MNMD), with institutional investors hold 68.71% of the company’s shares. The shares outstanding are 81.59M, and float is at 27.23M with Short Float at 36.65%. Institutions hold 68.23% of the Float.
Mind Medicine Inc (MNMD) Insider Activity
The most recent transaction is an insider sale by Barrow Robert, the company’s Chief Executive Officer. SEC filings show that Barrow Robert sold 19,106 shares of the company’s common stock on Dec 26 ’24 at a price of $7.43 per share for a total of $0.14 million. Following the sale, the insider now owns 0.53 million shares.
Mind Medicine Inc disclosed in a document filed with the SEC on Dec 26 ’24 that Liao Carrie (Chief Accounting Officer) sold a total of 2,273 shares of the company’s common stock. The trade occurred on Dec 26 ’24 and was made at $7.43 per share for $16888.0. Following the transaction, the insider now directly holds 97270.0 shares of the MNMD stock.
Still, SEC filings show that on Dec 26 ’24, Karlin Dan (Chief Medical Officer) disposed off 6,643 shares at an average price of $7.43 for $49357.0. The insider now directly holds 338,013 shares of Mind Medicine Inc (MNMD).
